Destiny Pharma plc
DEST.L · LSE
12/31/2023 | 6/30/2023 | 12/31/2022 | 6/30/2022 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -£2,997 | -£2,660 | -£3,315 | -£3,188 |
| Dep. & Amort. | £3 | £4 | £6 | £6 |
| Deferred Tax | £0 | £0 | £0 | £0 |
| Stock-Based Comp. | £268 | £208 | £258 | £276 |
| Change in WC | -£48 | £21 | -£166 | £181 |
| Other Non-Cash | -£864 | £591 | -£297 | £348 |
| Operating Cash Flow | -£3,639 | -£1,836 | -£3,515 | -£2,378 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -£0 | -£1 | -£1 | £0 |
| Net Acquisitions | £0 | £0 | £0 | £0 |
| Inv. Purchases | £0 | £0 | £0 | £0 |
| Inv. Sales/Matur. | £0 | £0 | £0 | £0 |
| Other Inv. Act. | £178 | £31 | £48 | £17 |
| Investing Cash Flow | £178 | £31 | £47 | £17 |
| Financing Activities | – | – | – | – |
| Debt Repay. | £0 | £0 | £0 | £0 |
| Stock Issued | £0 | £0 | £0 | £0 |
| Stock Repurch. | £0 | £0 | £0 | £0 |
| Dividends Paid | £0 | £0 | £0 | £0 |
| Other Fin. Act. | £0 | £6,745 | £0 | £6,086 |
| Financing Cash Flow | £0 | £6,745 | £0 | £6,086 |
| Forex Effect | £0 | £0 | £0 | £0 |
| Net Chg. in Cash | -£9,843 | £9,843 | -£8,371 | £8,371 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | £9,843 | £0 | £8,371 | £0 |
| End Cash | £0 | £9,843 | £0 | £8,371 |
| Free Cash Flow | -£3,639 | -£1,836 | -£3,516 | -£2,378 |